| 2.2 -1.99 (-47.49%) | 10-09 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 6.67  |
1-year : | 9.36 |
| Resists | First : | 5.71 |
Second : | 8.02 |
| Pivot price | 4.93 |
|||
| Supports | First : | 1.99 |
Second : | 1.65 |
| MAs | MA(5) : | 4.17 |
MA(20) : | 5.3 |
| MA(100) : | 6.91 |
MA(250) : | 7.55 |
|
| MACD | MACD : | -0.8 |
Signal : | -0.6 |
| %K %D | K(14,3) : | 7 |
D(3) : | 11.5 |
| RSI | RSI(14): 17.4 |
|||
| 52-week | High : | 23.21 | Low : | 1.99 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ MLEC ] has closed below the lower bollinger band by 26.9%. If price is in a downtrend band; this downward trend might continue. However a short term pullback inside the band is likely. Bollinger Bands are 105.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 4.43 - 4.46 | 4.46 - 4.48 |
| Low: | 1.95 - 1.97 | 1.97 - 1.99 |
| Close: | 2.17 - 2.2 | 2.2 - 2.22 |
Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans, and yeast, as well as lupin and peas. The company is based in Grand Cayman, Cayman Islands.
Tue, 29 Sep 2026
MLEC Forecast — Price Target — Prediction for 2027 - TradingView
Sat, 15 Aug 2026
Moolec Science (MLEC) Edges Higher, Holds Above Key Support at $7.20 - Initial Balance - dars.gov.et
Mon, 27 Jul 2026
Moolec Science SA Revenue Breakdown – NASDAQ:MLEC - TradingView
Tue, 26 May 2026
MLEC - Moolec Science SA Stock Price and Quote - Finviz
Thu, 14 May 2026
Moolec Science completes 2026 safflower planting campaign - Investing.com
Tue, 07 Apr 2026
Moolec Science Announces Breakthrough in Molecular Farming With Successful Expression of Bovine Myoglobin in Pea Seeds - ACCESS Newswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 1 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 21 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 3 (K) |
| Shares Short P.Month | 9 (K) |
| EPS | -199.03 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.69 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -0.02 |
| PEG Ratio | 0 |
| Price to Book value | 3.14 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|